During the past decade, Orange Coast Blood and Cancer Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange Coast Blood and Cancer Care" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Genomic Health®, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Orange Coast Blood and Cancer Care" are "Breast Cancer" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Orange Coast Blood and Cancer Care" in a lesser frequency.

Most popular intervention types in "Orange Coast Blood and Cancer Care" are "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "Goserelin" (1 trials), "Letrozole" (1 trials), "Oncotype DX Breast Recurrence Score" (1 trials) and "Palbociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orange Coast Blood and Cancer Care" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Orange Coast Blood and Cancer Care". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orange Coast Blood and Cancer Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orange Coast Blood and Cancer Care, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".